Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000327648 | SCV000342086 | benign | not specified | 2016-05-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000327648 | SCV000520273 | benign | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590412 | SCV000699361 | benign | not provided | 2016-11-25 | criteria provided, single submitter | clinical testing | Variant summary: The ADAMTS2 c.1238+18G>A variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, this variant may strengthen a crptic 5' splicing donor site. These predictions have yet to be confirmed by functional studies. This variant was found in 22005/70686 control chromosomes (2714 homozygotes) at a frequency of 0.3113063, which is approximately 108 times the estimated maximal expected allele frequency of a pathogenic ADAMTS2 variant (0.0028868), suggesting this variant is likely a benign polymorphism. In addition, the variant of interest has been cited as Benign by a reputable database/clinical laboratory. Taken together, this variant is classified as benign. |
Genome- |
RCV000611691 | SCV001762707 | benign | Ehlers-Danlos syndrome, dermatosparaxis type | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000611691 | SCV002390692 | benign | Ehlers-Danlos syndrome, dermatosparaxis type | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000611691 | SCV000734398 | benign | Ehlers-Danlos syndrome, dermatosparaxis type | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000611691 | SCV000745662 | benign | Ehlers-Danlos syndrome, dermatosparaxis type | 2014-02-04 | no assertion criteria provided | clinical testing |